Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.25B P/E 84.04 EPS this Y 912.50% Ern Qtrly Grth 315.20%
Income 6.76M Forward P/E 70.04 EPS next Y 48.10% 50D Avg Chg 3.00%
Sales 190.78M PEG - EPS past 5Y - 200D Avg Chg 8.00%
Dividend N/A Price/Book 6.38 EPS next 5Y - 52W High Chg -9.00%
Recommedations 2.20 Quick Ratio 1.17 Shares Outstanding 30.35M 52W Low Chg 62.00%
Insider Own 42.92% ROA 2.31% Shares Float 13.23M Beta 1.47
Inst Own 45.19% ROE 5.31% Shares Shorted/Prior 127.50K/134.29K Price 37.82
Gross Margin 80.88% Profit Margin 3.55% Avg. Volume 43,866 Target Price 54.33
Oper. Margin 7.25% Earnings Date Aug 8 Volume 78,748 Change -2.98%
About Docebo Inc.

Docebo Inc. operates as a learning management software company that provides artificial intelligence (AI)-powered learning platform in North America and internationally. It offers Learning Management System (LMS) to train internal and external workforces, partners, and customers. The company's cloud platform consists of a learning suite, which includes Docebo Learn LMS, a cloud-based learning platform that allows learning administrators to deliver personalized learning; Docebo Shape, an AI-based learning content creation tool, which enables learning administrators to turn internal and external resources into engaging, multilingual, and microlearning content to share across the business; Docebo Content that allows off-the-shelf learning content by partnering content specialist; Docebo Learning Impact, a learning measurement tool that enables administrators to prove and improve training programs; Docebo Learn Data, which gives a comprehensive view on learning data to business results; Docebo Connect that connects Docebo to custom tech stack and making integrations; and Docebo Flow that allows businesses to directly inject learning into the flow of work. It also offers Docebo for Salesforce, a native integration that leverages Salesforce's application programming interface and technology architecture to produce a learning experience; Docebo Embed that allows original equipment manufacturers to embed and re-sell Docebo as a part of their software; Docebo Mobile App Publisher product that allows companies to create and publish own branded version of Docebo Go.Learn mobile learning applications; Docebo Extended Enterprise which breeds customer education, partner enablement, and retention; Docebo Discover, Coach & Share that enhances the learning experience to create a culture of social learning; and Docebo for Microsoft Teams, that brings learning directly into Microsoft Teams. The company was founded in 2005 and is headquartered in Toronto, Canada.

Docebo Inc. News
05/11/24 Docebo First Quarter 2024 Earnings: EPS Beats Expectations
05/09/24 Docebo Reports First Quarter 2024 Results
04/30/24 Docebo Announces Participation in Upcoming Investor Conferences in May
04/29/24 Docebo Inc.'s (TSE:DCBO) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
04/17/24 Docebo to Host First Quarter Fiscal 2024 Conference Call
04/12/24 At CA$63.78, Is Docebo Inc. (TSE:DCBO) Worth Looking At Closely?
04/02/24 Is Docebo (DCBO) Well-Positioned to Sustain Strong Revenue Growth?
03/26/24 Docebo Announces Participation in Upcoming Investor Conferences in April
03/12/24 Estimating The Intrinsic Value Of Docebo Inc. (TSE:DCBO)
02/28/24 Docebo Announces Participation in Upcoming Investor Conferences in March
02/25/24 Docebo Full Year 2023 Earnings: EPS Misses Expectations
02/23/24 Docebo Reports Fourth Quarter and Fiscal Year 2023 Results
01/29/24 Docebo to Host Fourth Quarter Fiscal 2023 Conference Call
01/26/24 Morgan Stanley Hosts Virtual Discussion on AI with Docebo
01/16/24 Docebo Recognized with 7 Brandon Hall Group Excellence in Technology Awards 2023
01/02/24 Docebo Announces Participation in Upcoming Investor Conferences in January
12/29/23 Docebo Inc. Announces Results of its Substantial Issuer Bid
12/06/23 We Like These Underlying Return On Capital Trends At Docebo (TSE:DCBO)
11/22/23 Docebo Inc. Announces CEO Succession and Substantial Issuer Bid
11/20/23 Docebo Inc.'s (TSE:DCBO) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
DCBO Chatroom

User Image erevnon Posted - 3 days ago

Needham reiterates Docebo $DCBO at Buy and maintains a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

User Image saskatrade Posted - 3 days ago

$DCBO easy add when back over 38 imo

User Image Sfsfsf Posted - 3 days ago

$DCBO

User Image Stocksrunner Posted - 4 days ago

Target Price Updates: $CLRB: Cellectar Biosciences sees target price raised as it maintains an outperform rating on strong Q1 results. $DCBO: Docebo target price cut by Canaccord Genuity due to growth outlook concerns. https://stocksrunner.com/target Stay informed and adjust your strategies!

User Image erevnon Posted - 4 days ago

Scotiabank maintains Docebo $DCBO at Sector Outperform and lowers the price target from $65 to https://marketsblock.com/stock-upgrades-and-downgrades/

User Image Sfsfsf Posted - 4 days ago

$DCBO this stock is about to pop, I would YOLO everything on this if I were you guys.

User Image anachartanalyst Posted - 4 days ago

https://anachart.com/market-update/may-14th-2024/ $FULC $AGYS $DCBO

User Image erevnon Posted - 5 days ago

Morgan Stanley maintains Docebo $DCBO at Overweight and lowers the price target from $65 to https://marketsblock.com/stock-upgrades-and-downgrades/

User Image erevnon Posted - 5 days ago

Goldman Sachs maintains Docebo $DCBO at Neutral and lowers the price target from $55 to https://marketsblock.com/stock-upgrades-and-downgrades/

User Image Fullratio Posted - 5 days ago

$DCBO debt is 96% smaller than its equity: https://fullratio.com/stocks/nasdaq-dcbo/docebo

User Image Thestocktraderhubzee Posted - 5 days ago

$DCBO CIBC Maintains Outperformer on Docebo, Lowers Price Target to $53

User Image LoganDelwynn Posted - 6 days ago

$DCBO the P.E. is 160 and Forward PE Ratio : 41.84 (As Of May 12th 2024)

User Image Thestocktraderhubzee Posted - 6 days ago

WATCHLIST MAY 13 2024 $MUX HC Wainwright & Co. Maintains Buy on McEwen Mining, Raises Price Target to $15 $CMPS HC Wainwright & Co. Reiterates Buy on Compass Pathways, Maintains $120 Price Target $INAB HC Wainwright & Co. Maintains Buy on IN8bio, Lowers Price Target to $12.5 $DCBO Needham Maintains Buy on Docebo, Lowers Price Target to $45 $IBTA Goldman Sachs Initiates Coverage On Ibotta with Neutral Rating, Announces Price Target of $103

User Image erevnon Posted - 6 days ago

Needham maintains Docebo $DCBO at Buy and lowers the price target from $63 to https://marketsblock.com/stock-upgrades-and-downgrades/

User Image Pixiu Posted - 1 week ago

$DCBO have a look over the weekend at this company’s website, the demo, and customer list and enjoy buying this hidden gem at a discount. Hidden AI play with a very unique application $SPY $QQQ

User Image LoganDelwynn Posted - 1 week ago

$DCBO a selling Friday, index dipping and earnings all pulling this down. I'm as confident as when CM.to(CIBC- Canadian Imperial Bank of Canada) hit $48 that it'll bounce back in soon order.

User Image Stocksrunner Posted - 1 week ago

πŸ“ŠKey Technical Indicators Update: $ACLX, $DCBO, $AMR, and $PBF slipped below their 200-day moving averages, indicating possible bearish trends. πŸ“‰πŸ’”

User Image Stocksrunner Posted - 1 week ago

Friday's Brutal Sell-Off: Top Losers πŸ“‰ $MGNX - MacroGenics crashes hard after disappointing mid-stage prostate cancer drug data. $FAT - Fat Brands chairman indicted in $47M sham loan scheme. $DCBO - Docebo breaks below 200-day moving average as selling intensifies. $RVNC - Analysts slash Revance Therapeutics forecasts post-Q1 miss. $FROG - JFrog plunges on Q1 earnings disappointment. This software stock is defectively priced now. https://stocksrunner.com/trending Absolutely brutal trading session for many corners of the market today.

User Image Starkravingmad Posted - 1 week ago

$DCBO below it's price from over a year ago with nothing but earnings beats and decent guidance all along the way

User Image yogibearacallz Posted - 1 week ago

$DCBO $SPY. Let's Go DeeBo. Let's go DeeBo. Killer earnings. Killer dip. In

User Image LoganDelwynn Posted - 1 week ago

$DCBO Great time to add more. I added at 41 now at 51 too.

User Image Pixiu Posted - 1 week ago

$DCBO very few people have yet to discover this as a great AI play, and this one likely gets bought and tucked into a bigger company

User Image Doozio Posted - 1 week ago

$DCBO appears some software stonks are starting to stink. πŸ‘πŸ‘€

User Image Stocksrunner Posted - 1 week ago

πŸ“ˆ Today's Unusual Volume Detected! πŸ“Š 1️⃣ $SG: Significant movement detected. Potential reasons: News catalysts driving interest. 2️⃣ $MGNX: MacroGenics experiences high volume amid earnings news. Traders analyzing Q1 results. 3️⃣ $DCBO: Docebo Inc. sees increased activity following earnings presentation. Market reacting to financial performance. 4️⃣ $NVAX: Novavax surges with multibillion-dollar deal announcement. Investor excitement propels trading volume. πŸ“Š Keep an eye on these stocks for potential trading opportunities as market dynamics shift! https://stocksrunner.com/trending

User Image Jamesiam Posted - 1 week ago

$DCBO AI will crush them

User Image Starkravingmad Posted - 1 week ago

$DCBO down 400 million on earnings beat πŸ€·β€β™‚οΈ

User Image saskatrade Posted - 1 week ago

$DCBO feels overdone, but not quite adding yet

User Image Stocksrunner Posted - 1 week ago

πŸ“‰ Today's Top Losers πŸ“‰ 1️⃣ $MGNX: MacroGenics faces rough waters with lackluster Q1 results, investors wary. 2️⃣ $AEHL: Antelope Enterprise disappoints with 78% revenue growth, fails to impress. 3️⃣ $LAW: Cs Disco struggles as Q1 earnings call leaves investors skeptical. 4️⃣ $PLX: Protalix BioTherapeutics reports increased Q1 losses, misses revenue estimates. 5️⃣ $DCBO: Docebo Inc. Q1 earnings call fails to inspire, market sentiment turns sour. πŸ“‰ It's a tough day for these companies in the market. Stay cautious, traders. https://stocksrunner.com/trending

User Image epsguid Posted - 1 week ago

$DCBO reported earnings of $0.18, consensus was $0.14 via @eWhispers #epsbeat http://eps.sh/d/dcbo

User Image DonCorleone77 Posted - 1 week ago

$DCBO Docebo sees FY24 revenue growth between 17.0%-18.5% Sees FY24 adjusted EBITDA as a percentage of total revenue between 14.5%-15.5%.

Analyst Ratings
Goldman Sachs Buy Mar 15, 21